Links lead to other www sites on the Internet. The IBS Self Help and Support Group has not endorsed and makes no warranty as to the accuracy of the information contained within them and assumes no liability related to their use.

 

• IBS Patients: Their Illness Experience and Unmet Needs Survey Results (05/01/09) (IFFGD)
• New Evidence-Based Systematic Review on Management of Irritable Bowel Syndrome (12/18/08) (ACG)
• The brain-gut connection, Treatments usually prescribed for mental illness are now being used for physical pain (11/17/08) (Maclean's)
• American College of Gastroenterology's (ACG) Scientific Meeting (10/06/08) (ACG)
• World Digestive Health Day 2008 (05/29/08) (WGO)
• Sucampo Pharmaceuticals Obtains FDA Approval for AMITIZA for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women (04/29/08) (Sucampo)
• Irritable Bowel Syndrome Research and Treatment Act (04/08/08) (IFFGD)
• Zelnorm will no longer be available under a treatment investigational new drug application (04/02/08) (FDA)
• Women with irritable bowel syndrome unable to regulate pain effectively (01/08/08) (UCLA)
• What Patients Know About Irritable Bowel Syndrome (IBS) and What They Would Like to Know (09/18/07) (Amer. Journal Gastro)
• Pregabalin Reduces Symptoms of Irritable Bowel Syndrome (09/14/07) (Gut)
• Staying silent in marital spats a killer for women (08/20/07) (Psychosomatic Medicine)
• Personality may influence irritable bowel syndrome (08/10/07) (Gut)
• Zelnorm to be made available to US patients under restricted access program (07/27/07) (Novartis)
• Sucampo Pharmaceuticals Submits Supplemental New Drug Application for Lubiprostone to Treat Irritable Bowel Syndrome with Constipation (07/12/07) (Sucampo)
• How talking therapy can soothe IBS (07/02/07) (Times)
• Irritable Bowel Syndrome Self Help and Support Group invited by Revolution Health to be a partner for its first Online Health Fair (06/18/07) (Revolution Health)
• Probiotics Offer a Natural Option for IBS Sufferers (04/09/07) (PGHSI)
• Clinically-Proven Probiotic for Irritable Bowel Syndrome (IBS) Symptoms (04/06/07) (Ganeden Biotech)
• The Irritable Bowel Syndrome Self Help and Support Group Announces New Book IBS Chat: Real Life Stories and Solutions (04/02/07) (IBSGroup)
• 7 Common Myths About Irritable Bowel Syndrome (04/02/07) (UMHS)
• April is IBS Awareness Month (04/01/07) (IBSGroup)
• FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons (3/30/07) (FDA)
• Overly Anxious and Driven People Prone to Irritable Bowel Syndrome (2/26/07) (Gut)
• Medical Nutrition Company Launches IBSACOL ADVANCED(TM) for IBS (2/20/07) (Solace Nutrition)
• Revolution Health Launches in Preview Mode and refers visitors to IBS Self Help and Support Group (1/22/07) (Revolution Health)
• Jeffrey Roberts chosen as guest expert in November for Women's Health Matters site (11/24/06) (Women's Health Matters)
• New Survey Shows Constipation Sufferers Fail To Use Most Effective Remedies (10/25/06) (Boehringer Ingelheim GmbH)
• IBS Hints at Migraine, Fibromyalgia, and Depression (09/28/06) (BMC Gastroenterology)
• Low Birth Weight Ups Risk of Irritable Bowel Syndrome (09/28/06) (Gut)
• Patient Symposium 2006 - UNC Center for Functional GI & Motility Disorders (07/15/06) (IBS Group)
• New Study Demonstrates That Bifantis(TM) (Bifidobacterium infantis 35624) Offers Relief for Women With IBS (07/11/06) (P&G Health Sciences)
• New Data Shed Light On The Global Incidence Of Constipation (05/23/06) (Boehringer Ingelheim)
• Irritable Bowel Syndrome Aggregates Strongly in Families (05/23/06) (Mayo Clinic)
• Zelnorm(R) May Be a Safe and Effective Treatment for Additional Group of IBS Patients With a Mixed Bowel Pattern (05/22/06) (Novartis)
• AMITIZA(TM) (lubiprostone) May Help Improve Symptoms of Irritable Bowel Syndrome with Constipation (05/21/06) (Sucampo)
• Launching of Rome III (AGA)
• April is IBS Awareness Month (04/01/06) (IFFGD)
• CHMP recommends against approval of Novartis' Zelnorm for treatment of IBS-C (03/25/06) (Saffron Media)
• Anticholinergic Drugs Linked to Mental Impairment in Elderly People (02/01/06) (BMJ)
• Sucampo Obtains FDA Approval for Amitiza as Treatment for Chronic Idiopathic Constipation (01/31/06) (Sucampo)
• First Probiotic Clinically Proven to Benefit Both IBS and Crohn's Disease Patients Achieves High Conversion Rates Among Samplers of the Product (01/19/06) (Ganeden Biotech)
• Journal of Consumer Health on the Internet selects the IBS Group website as as an Editor's Select Site (2005) (JCHI)
• For Sufferers of GI Disorders, Holidays Are Anything But a Gas (12/21/05) (Newhouse)
• Family relationships and mind-body attributions (12/31/05) (Social Science & Medicine)
• Solvay Pharmaceuticals suspends Cilansetron registration activites in the U.S., while discussions in Europe continue (11/29/05) (Solvay)
• Rifaximin Helps in the Treatment of Irritable Bowel Syndrome (11/02/05) (Salix)
• Beneficial bacteria probiotic Bifidobacterium infantis 35624 stabilizes bowel movement in IBS (11/01/05) (ACG)
• Knowledge, Attitudes and Preferences of IBS Sufferers (10/31/05) (ACG)
• Tegaserod even more effective on retreatment of IBS constipation (10/24/05) (UEGW)
• The Other Brain Also Deals With Many Woes (8/23/05) (NY Times)
• Blood Testing Links Common Foods and IBS (7/12/05) (AJG)
• Patients Speak Out About Cilansetron (4/01/05) (IBSPAG & IBS Association)
• FDA Requests Further Data on Cilansetron, Solvay's Proposed Treatment for IBS-D (4/01/05) (Solvay)
• Canadian Patient Groups Proclaim April as Irritable Bowel Syndrome Awareness Month (04/01/05) (IBSGroup)
• April is IBS Awareness Month (04/01/05) (IFFGD)
• Solvay Pharmaceuticals, Inc. Announces 90-Day Extension of FDA Review of the New Drug Application for Cilansetron for the Treatment of Irritable Bowel Syndrome with Diarrhea Predominance (IBS-D) (12/20/04) (Solvay)
• New Remedies for a Frustrating Illness. But Do They Work? (12/07/04) (NY Times)
• Mayo Clinic Researchers Find Link Between IBS, Alcoholism and Mental Illness (11/05/04) (Novartis)
• Zelnorm Study Shows Significant Improvement in Work Productivity (11/03/04) (Novartis)
• Cilansetron Improves Health Related Quality of Life in Phase III Clinical Trial Patients with IBS with Diarrhea Predominance (11/01/04) (Solvay)
• Initiation of Phase I Clinical Trial for Novel, ORAL IBS Treatment (11/01/04) (Microbia)
• Cybill Shepherd Leads Amazing Women Campaign to Help IBS Sufferers (10/20/04) (NWHRC)
• Cilansetron NDA Filing Accepted for Priority Review by the FDA for the Treatment of Irritable Bowel Syndrome with Diarrhea Predominance (9/01/04) (Solvay)
• FDA Approves Zelnorm as the First Rx Therapy For Chronic Constipation (8/20/04) (Novartis)
• Approval Recommended for Use of Zelnorm in Chronic Constipation by FDA Advisory Committee (7/14/04) (Novartis)
• Solvay Pharmaceuticals, Inc. submits NDA to the FDA for Cilansetron (7/1/04) (Solvay)
• Irritable Bowel Linked to High Surgery Rates (6/29/04) (Reuters)
• Zelnorm Action Group and IBS Self Help Group speak on behalf of the Chronic Constipation and Irritable Bowel Syndrome Sufferer (6/17/04) (IBSGroup)
• Molecular Defect Found for the First Time in IBS Patients (6/9/04) (Novartis)
• FDA Updates Zelnorm Labeling with New Risk Information (4/28/04) (FDA)
• 'Leaky gut' leads to irritable bowels (3/31/04) (McMaster University)
• Gastrotech and Eli Lilly continue the development of peptides to treat IBS (3/31/04) (Gastrotech Pharma A/S)
• Lotronex (Alosetron HCl) 0.5mg Tablets Available in US (3/10/04) (GlaxoSmithKline)
• When Eating hurts: Irritable bowel syndrome makes eating an agony and daily life a misery for millions of Canadians (02/04) (Canadian Living Magazine)
• Irritable Bowel Syndrome Association, accompanied by Wellness Foods Inc, to attend 8th Annual Women's Health Matters Forum and Expo in Toronto on January 16-17, 2004 (IBS Association)
• Irritable Bowel Syndrome's Possible Genetic Link Studied by Mayo Clinic Researchers (12/10/03) (Mayo Clinic)
• Brain Explains Pain Differences in Men and Women (11/05/03) (UCLA)
• Combo Treatment Best for IBS: New Approach uses GI and Psychoanalyst (11/03/03) (WebMD)
• Hypnosis May Be Useful IBS Treatment (10/21/03) (WebMD)
• Many Patients with Irritable Bowel Also Suffer from Dyspepsia (10/17/03) (ACG)
• Diet may play role in IBS and dyspepsia (10/13/03) (ACG)
• Hypnosis gaining respectability among doctors, patients (10/12/03) (Pioneer Press)
• Forest to Discontinue Development in U.S. of Dexloxiglumide for Irritable Bowel Syndrome (IBS) (10/1/03) (Forest Laboratories, Inc.)
• Inflammatory Bowel Disease and Irritable Bowel Syndrome: Separate or Unified? (07/15/03) (Gastroenterology)
• Postinfectious irritable bowel syndrome (06/03) (Gastroenterology)
• Clinical Study Confirms PROBACTRIX(TM) Highly Promising for IBS Symptoms (06/11/03) (BioBalance)
• New Drug Approach to Irritable Bowel (05/29/03) (Reuters Health)
• Tegaserod Helpful in Irritable Bowel Syndrome (05/29/03) (Medscape)
• Probiotics Significantly Reduce Symptoms of IBS, Ulcerative Colitis (05/21/03) (Medscape)
• Pattern-Specific Brain Activation and Personalities Seen in Irritable Bowel Syndrome (05/21/03) (Medscape)
• Solvay Pharma granted patent for IBS medication Cilansetron (05/20/03) (United States Patent)
• New study shows Zelmac® is effective and well tolerated for chronic constipation (05/20/03) (Novartis)
• IBS: Suffering in Silence (02/03) (Today's Dietitian)
• Still Irritable, Still Waiting: After Return to Market, Lotronex Can Be Hard to Get (02/10/03) (Washington Post)
• WebMd with Aol Health - Top 10 health Stories of 2002 - #10 Lotronex (12/31/02) (WebMD with Aol Health)
• The gut has a mind of its own (12/31/02) (The Globe and Mail)
• Lotronex Action Group applauds pharmaceutical for making Lotronex Tablets available (11/20/02) (IBSGroup)
• Lotronex® Tablets now available for women with severe diarrhea-predominant irritable bowel syndrome (11/20/02) (GSK)
• In J.F.K. File, Hidden Illness, Pain and Pills (and Irritable Bowel Syndrome) (11/16/02) (NYTimes)
• Paroxetine Reduces IBS Symptoms in Patients Not Responsive to Fiber Alone (10/24/02) (ACG)
• GSK expects Lotronex to be re-introduced in November (10/23/02) (GSK)
• American College of Gastroenterology Gives Zelnorm 'Grade A' Recommendation (10/22/02) (Novartis)
• New study shows Zelmac® effective and safe for people with non-diarrhea IBS (10/21/02) (Novartis)
• Fructose Intolerance Could Be the Culprit in Unexplained Abdominal Pain and Gas (10/21/02) (ACG)
• Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron (10/08/02) (Gastroenterology)
• Lipid-Induced Intestinal Gas Retention in Irritable Bowel Syndrome (9/02) (Gastroenterology)
• DOR BioPharma Options Intellectual Property for the Use of Oral Anti-Inflammatory Drugs for Irritable Bowel Syndrome (09/26/02) (DOR BioPharma)
• Alizyme Completes Patient Recruitment in Phase IIb Clinical Trial of Renzapride in Irritable Bowel Syndrome (09/25/02) (Alizyme)
• Inhibitory Effect of Lipids on Intestinal Gas Transit Increased in IBS Patients (09/20/02) (Reuters Health)
• Serotonin-Transporter Polymorphism Influences Response to Alosetron (09/03/02) (Reuters)
• Patient groups applaud the availability of new therapy for women with Irritable Bowel (07/31/02)
• Des groupes de patients se réjouissent de l'arrivée d'un nouveau traitement pour les femmes atteintes du syndrome du colon irritable (07/31/02) (IBSGroup/CSIR/ASII)
• Zelnorm Action Group and IBS Self Help Group comment about FDA's Approval of Zelnorm (07/24/02) (IBSGroup)
• FDA Approves Zelnorm for Irritable Bowel Syndrome in Women With Constipation (07/24/02) (Novartis)
• Results of IBS IN CANADA SURVEY show significance of disorder on life and living (07/24/02)
• Les résultats du SONDAGE CANADIEN SUR LE SCI révèlent l'importance de cette affection sur la qualité de vie (07/24/02) (Novartis)
• IBS Survey Seeks Information about the Quality of Life for a Canadian IBS Sufferer (07/09/02)
• Le sondage sur le SCI vise à réunir des données sur la qualité de vie des Canadiens atteints du SCI (07/09/02) (IBSGroup/Ipsos-Reid)
• Lotronex Action Group and IBS Self Help Group comment about FDA's Approval to allow Restricted Access to Lotronex (06/07/02) (IBSGroup)
• FDA Approves Restricted Marketing Of Lotronex (06/07/02) (FDA)
• Lotronex® tablets to be re-introduced for women with severe diarrhea-predominant IBS (06/07/02) (GlaxoSmithKline)
• New Survey Shows That Less Than Two Percent Of People Are Aware That Irritable Bowel Syndrome Is More Widespread Than Asthma, Depression And Diabetes (05/20/02) (Novartis)
• Advisers to the U.S. Food and Drug Administration say the agency should reverse its decision to ban a drug (04/24/02) (National Public Radio)
• Panel Advises Lifting Ban on Drug for Bowel Ailment (04/24/02) (NYTimes)
• Poll Results: What restrictions are IBS sufferers willing to accept for access to IBS medications? 1 2 (04/22/02) (IBSGroup)
• Zelnorm approved for marketing in Canada and Brazil (03/19/02) (Novartis)
• FDA: Letter to IBS Patients (01/23/02) (CDER)
• US FDA sets April 23 meeting on Glaxo's Lotronex (Reuters)
• Glaxo says Lotronex may return, but no blockbuster (Reuters) 
• Novartis' irritable bowel syndrome (IBS) treatment Zelmac® approved in Switzerland (Novartis)
• New data further underlines the safety and efficacy of Zelmac® (tegaserod) in treating multiple symptoms of Irritable Bowel Syndrome (IBS) (Novartis)
• Family setting influences irritable bowel syndrome (Reuters Health)
• Easily treatable condition often unrecognized in IBS patients (Reuters Health)
• Solvay Pharmaceuticals moves ahead in Irritable Bowel Syndrome with Cilansetron (Solvay)
• Novartis launches irritable bowel syndrome treatment Zelmac® in first market, Mexico (Novartis)
• Irritable Bowel Syndrome Self Help Group adds Topic of the Month forum moderated by Mind-Body Digestive Center (IBSgroup)
• 40 Million Americans Suffering From IBS Forced to Wait Even Longer for Relief: FDA Denial Leave Patients Desperate for New Therapies (Right-Click "Save Target As") (IBSGroup)
• FDA Requests Additional Data on Irritable Bowel Syndrome (IBS) Drug Zelnorm(TM) (tegaserod maleate) (Novartis)
• Novartis Zelnorm Drug Not Approved in US (Reuters)
• Patients Demand Lotronex (CBS Evening News)
• Abdominal Pain and Constipation Significantly Reduced by Zelnorm(TM) (tegaserod maleate) in Women with Irritable Bowel Syndrome (Novartis)
• Controversial Glaxo bowel drug may make comeback (Reuters)
• New Data released about Lotronex (IBSgroup)
• Low-lactose diet does not benefit IBS patients with lactose intolerance (Reuters Health)
• Prucalopride accelerates gastrointestinal transit in patients with constipation (Reuters Health)
• Lotronex Action Group petition demands that Lotronex be made available (PR Web)
• Novartis Pharmaceuticals Confirms the Safety and Efficacy of Zelmac™ (tegaserod maleate) (Novartis)
• Update on Treatments for Irritable Bowel Syndrome (UNC Center for Functional GI & Motility Disorders)
• Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome (ACG)
• Novartis' Zelmac shows efficacy in phase III studies (Reuters Health)
• F.D.A. Pulls a Drug, and Patients Despair by Denise Grady (NYTimes)
• IBS Self Help Group reacts to withdrawal of Lotronex by Glaxo Wellcome (PR Web)
• Glaxo Wellcome withdraws Lotronex from the US market (GlaxoSmithKline)
• DrugVoice Study Reveals Multiple Opportunities to Improve Satisfaction Among IBS Sufferers (PRNewswire)
• FDA re-examines Lotronex after death reports (Associated Press & Reuters Health)
• Symptoms alone differentiate between IBS, organic disease, and food allergy (Reuters Health)
• Novartis and Bristol-Myers Squibb announce strategic alliance for Zelmac (Novartis)
• IBS Self Help Group invited to speak at Irritable Bowel Syndrome Symposium (PR Web)
• IBS Self Help Group Witnessing Explosive Growth for its Irritable Bowel Syndrome Website and Bulletin Board (PR Web)
• FDA warns women about side effects from irritable bowel treatment (AP)
• Bowel gas volume useful in diagnosing irritable bowel syndrome (Reuters Health)
• Novartis Pharmaceuticals Corporation Receives FDA Approvable Letter for Zelmac(TM) (PRNewswire)
• IBS Self Help Group continues to grow IBS Bulletin Board by adding Parkview Publishing's IBS and Fibromyalgia Bulletin Board (PR Web)
• Independent Study Uncovers New Syndrome for Chronic Diarrhea (PRNewswire)
• Irritable bowel symptoms may herald inflammatory enteric neuropathy (Reuters Health)
• Emotional factors may affect irritable bowel syndrome and vice versa (Reuters Health)
• FDA begins campaign to warn of medicines' side effects (Nando Media-Associated Press)
• FDA Advisory Committee recommends approval of Zelmac® for the treatment of irritable bowel syndrome in women (Novartis)
• Central fear circuits less activated in IBS patients (Reuters Health)
• Behavioral Therapy Improves Management of Irritable Bowel Syndrome (Reuters Health)
• FDA Grants Priority Review For Zelmac (Tegaserod) For Irritable Bowel Syndrome (Doctor's Guide)
• Study in Lancet Describes Efficacy; Safety Record of Newly Approved Drug for Irritable Bowel Syndrome (Glaxo)
• FDA Approves Glaxo Wellcome Medicine Lotronex™ (alosetron hydrochloride) for the Treatment of Irritable Bowel Syndrome in Women (Glaxo)
• Video:New Hope for Millions Of Women Suffering From IBS (Medialink)
• The Wisdom of the Gut (U.S. News & World Report)
• Treatment of Irritable Bowel Syndrome and Functional Constipation: New Insights by Nicholas J. Talley, MD, PhD (Medscape)
• Toward a Positive and Comprehensive Diagnosis of Irritable Bowel Syndrome by Yehuda Ringel, MD, and Douglas A. Drossman, MD (Medscape)
• Kelsey and Camille Grammer Speak Out on Major Women's Health Issue (PR NewsWire)
• American College of Gastroenterology Discuss Common Gastrointestinal and Medical problems in Women (ACG)
• FDA Advisory Panel Recommends Lotronex™ For IBS Symptoms (Doctor's Guide)
• New Drug Relieves Symptoms of Irritable Bowel Syndrome in Females (EurekAlert!)
• Alosetron Yields Relief In Non-Constipated Women With IBS (Doctor's Guide)
• Tegaserod Reduces Discomfort, Improves Bowel Function (Doctor's Guide)
• New Treatments Show Promise For IBS And Chronic Constipation (Doctor's Guide)